Top Wall Street Forecasters Revamp Owens & Minor Expectations Ahead Of Q2 Earnings

Benzinga

Aug 11

Owens & Minor, Inc. (NYSE:OMI) will release earnings results for the second quarter before the opening bell on Monday, Aug. 11.

Analysts expect the Glen Allen, Virginia-based company to report quarterly earnings at 28 cents per share, down from 36 cents per share in the year-ago period. Owens & Minor projects to report quarterly revenue at $2.73 billion, compared to $2.67 billion a year earlier, according to data from Benzinga Pro.

On June 5, Owens & Minor announced it terminated its Rotech Healthcare acquisition.

Owens & Minor shares rose 12.4% to close at $7.09 on Friday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

Baird analyst Eric Coldwell maintained a Neutral rating and boosted the price target from $9 to $10 on June 6, 2025. This analyst has an accuracy rate of 61%.
JP Morgan analyst Michael Minchak maintained an Underweight rating and cut the price target from $14 to $10 on March 10, 2025. This analyst has an accuracy rate of 68%.
UBS analyst Kevin Caliendo maintained a Buy rating rating and cut the price target from $25 to $13 on Feb. 13, 2025. This analyst has an accuracy rate of 66%.

Considering buying OMI stock? Here’s what analysts think:

Read This Next:

Should You Buy Boeing? Jim Cramer Weighs In

Photo via Shutterstock

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2558342886"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2558342886\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2558342886?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-11 15:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2558342886","market":"hk","top_or_hot":-1,"title":"Top Wall Street Forecasters Revamp Owens & Minor Expectations Ahead Of Q2 Earnings","media":"Benzinga","content":"<html><body><p><strong>Owens &amp; Minor, Inc.</strong> (NYSE:OMI) will release earnings results for the second quarter before the opening bell on Monday, Aug. 11.</p>\n<p>Analysts expect the Glen Allen, Virginia-based company to report quarterly earnings at 28 cents per share, down from 36 cents per share in the year-ago period. Owens &amp; Minor projects to report quarterly revenue at $2.73 billion, compared to $2.67 billion a year earlier, according to data from Benzinga Pro.</p>\n<p>On June 5, Owens &amp; Minor announced it terminated its Rotech Healthcare acquisition.</p>\n<p>Owens &amp; Minor shares rose 12.4% to close at $7.09 on Friday.</p>\n<p>Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.</p>\n<p>Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.</p>\n<ul>\n<li>Baird analyst Eric Coldwell maintained a Neutral rating and boosted the price target from $9 to $10 on June 6, 2025. This analyst has an accuracy rate of 61%.</li>\n<li>JP Morgan analyst Michael Minchak maintained an Underweight rating and cut the price target from $14 to $10 on March 10, 2025. This analyst has an accuracy rate of 68%.</li>\n<li>UBS analyst Kevin Caliendo maintained a Buy rating rating and cut the price target from $25 to $13 on Feb. 13, 2025. This analyst has an accuracy rate of 66%.</li>\n</ul>\n<p>Considering buying OMI stock? Here’s what analysts think: </p>\n<figure><img decoding=\"async\" height=\"518\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/11030747/image-164-1024x518.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/11030747/image-164-1024x518.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/11030747/image-164-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/11030747/image-164-768x389.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/11030747/image-164.png 1106w\" width=\"1024\"/></figure>\n<p><strong>Read This Next: </strong></p>\n<ul>\n<li><strong>Should You Buy Boeing? Jim Cramer Weighs In</strong></li>\n</ul>\n<p>Photo via Shutterstock</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Wall Street Forecasters Revamp Owens & Minor Expectations Ahead Of Q2 Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Wall Street Forecasters Revamp Owens & Minor Expectations Ahead Of Q2 Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2025-08-11 15:11</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p><strong>Owens &amp; Minor, Inc.</strong> (NYSE:OMI) will release earnings results for the second quarter before the opening bell on Monday, Aug. 11.</p>\n<p>Analysts expect the Glen Allen, Virginia-based company to report quarterly earnings at 28 cents per share, down from 36 cents per share in the year-ago period. Owens &amp; Minor projects to report quarterly revenue at $2.73 billion, compared to $2.67 billion a year earlier, according to data from Benzinga Pro.</p>\n<p>On June 5, Owens &amp; Minor announced it terminated its Rotech Healthcare acquisition.</p>\n<p>Owens &amp; Minor shares rose 12.4% to close at $7.09 on Friday.</p>\n<p>Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.</p>\n<p>Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.</p>\n<ul>\n<li>Baird analyst Eric Coldwell maintained a Neutral rating and boosted the price target from $9 to $10 on June 6, 2025. This analyst has an accuracy rate of 61%.</li>\n<li>JP Morgan analyst Michael Minchak maintained an Underweight rating and cut the price target from $14 to $10 on March 10, 2025. This analyst has an accuracy rate of 68%.</li>\n<li>UBS analyst Kevin Caliendo maintained a Buy rating rating and cut the price target from $25 to $13 on Feb. 13, 2025. This analyst has an accuracy rate of 66%.</li>\n</ul>\n<p>Considering buying OMI stock? Here’s what analysts think: </p>\n<figure><img decoding=\"async\" height=\"518\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/11030747/image-164-1024x518.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/11030747/image-164-1024x518.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/11030747/image-164-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/11030747/image-164-768x389.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/11030747/image-164.png 1106w\" width=\"1024\"/></figure>\n<p><strong>Read This Next: </strong></p>\n<ul>\n<li><strong>Should You Buy Boeing? Jim Cramer Weighs In</strong></li>\n</ul>\n<p>Photo via Shutterstock</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OMI","symbol_name":"欧麦斯-麦能医疗","start_time":0,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/25/08/47023978/top-wall-street-forecasters-revamp-owens-minor-expectations-ahead-of-q2-earnings","article_id":"2558342886","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2558342886","pubTimestamp":1754896284,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":" ","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"OMI":"欧麦斯-麦能医疗"},"translate_title":"华尔街顶级预测师在第二季度财报公布前修改了欧文斯和米诺的预期","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OMI":1},"content_text":"Owens & Minor, Inc. (NYSE:OMI) will release earnings results for the second quarter before the opening bell on Monday, Aug. 11.\nAnalysts expect the Glen Allen, Virginia-based company to report quarterly earnings at 28 cents per share, down from 36 cents per share in the year-ago period. Owens & Minor projects to report quarterly revenue at $2.73 billion, compared to $2.67 billion a year earlier, according to data from Benzinga Pro.\nOn June 5, Owens & Minor announced it terminated its Rotech Healthcare acquisition.\nOwens & Minor shares rose 12.4% to close at $7.09 on Friday.\nBenzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.\nLet's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.\n\nBaird analyst Eric Coldwell maintained a Neutral rating and boosted the price target from $9 to $10 on June 6, 2025. This analyst has an accuracy rate of 61%.\nJP Morgan analyst Michael Minchak maintained an Underweight rating and cut the price target from $14 to $10 on March 10, 2025. This analyst has an accuracy rate of 68%.\nUBS analyst Kevin Caliendo maintained a Buy rating rating and cut the price target from $25 to $13 on Feb. 13, 2025. This analyst has an accuracy rate of 66%.\n\nConsidering buying OMI stock? Here’s what analysts think: \n\nRead This Next: \n\nShould You Buy Boeing? Jim Cramer Weighs In\n\nPhoto via Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}